LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling.
Qiang WangJinrong LiaoZhiyong HeYing SuDong LinLing XuHai-Peng XuJinghui LinPublished in: OncoTargets and therapy (2020)
LHX6 down-regulation may induce EGFR-TKIs resistance and increase the migration ability of HCC827/ER cells via activation of the Wnt/β-catenin pathway.